This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (14)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

CAPT. NORMAN M. KAPLAN, MC

AMA Arch Intern Med. 1959;103(2):219-223.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The use of promazine as a tranquilizing agent in the treatment of a variety of disease states has achieved widespread currency. Recent reports have appeared concerning its efficacy in the management of patients with both acute and chronic mental disturbances,^1,2 including alcoholism^3,4 and delerium tremens,⁵ as well as its use as a predelivery sedative.⁶

A prime factor leading to the extensive use of this drug has been the generally accepted belief that removal of the chloride ion from chlorpromazine leads to diminished toxicity without loss of therapeutic potency. It has been frequently stated that use of the drug is not attended by serious side-effects.^1-6 However, isolated reports of toxic complications, including agranulocytosis,^7-9 convulsions, and dermatitis,¹⁰ have appeared. Another complication, marked hypotension, which is more properly considered an anticipated pharmacologic effect, has been observed ^3,10 but is said to be "slight," ⁶ "moderate," ¹ and, in fact, "not encountered."⁵ Though mention . . . [Full Text PDF of this Article]

Author Affiliations
U. S. A. F.

From the Department of Internal Medicine, the University of Texas Southwestern Medical School, Dallas, Texas.

Footnotes
Submitted for publication May 22, 1958.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?